Regulatory

The USPTO Issues Notice of Allowance for New Patent Covering MediciNova’s Ibudilast (MN-166) to Prevent Metastasis of Eye Cancer

The USPTO Issues Notice of Allowance for New Patent Covering MediciNova’s Ibudilast (MN-166) to Prevent Metastasis of Eye Cancer

Shots: The USPTO has issued a Notice of Allowance to the patent application coveri...

Zai Lab and Innoviva Specialty Therapeutics Reports the NMPA’s Approval of Xacduro (sulbactam-durlobactam) for Hospital-Acquired and Ventilator-Associated Pneumonia

Zai Lab and Innoviva Specialty Therapeutics Reports the NMPA’s Approval of Xacduro (sulbactam-durlobactam) for Hospital-Acquired a...

Shots: The NMPA has approved Zai Lab’s Xacduro for treating hospital-acquire...

Amgen’s Imdelltra (Tarlatamab-dlle) Receives the US FDA’s Approval to Treat Extensive-Stage Small Cell Lung Cancer

Amgen’s Imdelltra (Tarlatamab-dlle) Receives the US FDA’s Approval to Treat Extensive-Stage Small Cell Lung Cancer

Shots: The US FDA has granted accelerated approval to Amgen’s Imdelltra (DLL...

BMS Reports the US FDA’s Accelerated Approval of Breyanzi for Treating Follicular Lymphoma (FL)

BMS Reports the US FDA’s Accelerated Approval of Breyanzi for Treating Follicular Lymphoma (FL)

Shots: The US FDA’s accelerated approval of Breyanzi for r/r FL adults treat...

The US FDA Rejects Dynavax’ Four-Dose Heplisav-B Regimen for Adults on Hemodialysis

The US FDA Rejects Dynavax’ Four-Dose Heplisav-B Regimen for Adults on Hemodialysis

Shots: The US FDA issued a Complete Response Letter (CRL) for the four-dose Heplis...

Roche Receives the US FDA’s Approval for HPV Self-Collection Solutions for Cervical Cancer

Roche Receives the US FDA’s Approval for HPV Self-Collection Solutions for Cervical Cancer

Shots: Roche has received the US FDA’s approval for its human papillomavirus...

Image